Trial design for Guo et al.1 Ara-C indicates cytarabine; MIT, mitoxantrone; IND, induction; and PSR, postremission treatment.

Trial design for Guo et al.1  Ara-C indicates cytarabine; MIT, mitoxantrone; IND, induction; and PSR, postremission treatment.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal